课题基金 / 基金详情

BASE AWARD

BASE AWARD
基础奖
批准号:
9568975
负责人:
ROBERT GIANNINI
金额:
$8.28万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-01-30 至 2017-07-30

项目摘要

项目成果

ROBERT GIANNINI的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Contractor will manufacture 1,000 hard gelatin capsules containing one to five (1-5) mg Aza-Td-Cyd under cGMP condition for clinical use (The actual dose will be provided by the Project Officer upon sending API). The formulation will be similar to 10 mg TD-Cyd capsules to fill a size 4 capsule, which color should be other than Swedish Orange. After QC release testing, please place 10 capsules per suitable size container and after inserting a pharmaceutical coil seal the container with induction sealer seal, label the bottles, and send the finished product to the Clinical Repository of NCI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NEXT DTP-23-017, PRODUCTION OF 0.25MG OF AZATDC AND TDCYD CAPSULES
  • 批准号:
    10948447
  • 项目类别:
  • 资助金额:
    $6.62万
  • 财政年份:
    2023
  • 负责人:
    ROBERT GIANNINI
  • 依托单位:
NExT DTP-23-019 GMP PRODUCTION OF 40MG CAPSULES OF Z-ENDOXIFEN
  • 批准号:
    10948454
  • 项目类别:
  • 资助金额:
    $14.0万
  • 财政年份:
    2023
  • 负责人:
    ROBERT GIANNINI
  • 依托单位:
SOCIETAL IS A SMALL BUSINESS CONCERN FOR DOSAGE FORM DEVELOPMENT, MANUFACTURE, AND STABILITY STUDIES OF NCGC72
  • 批准号:
    10953952
  • 项目类别:
  • 资助金额:
    $18.29万
  • 财政年份:
    2023
  • 负责人:
    ROBERT GIANNINI
  • 依托单位:
PRODUCTION OF AMMONIUM TETRATHIOMOLIBDATE (ATTM) CAPSULES FOR USE IN CLINICAL TRIALS
  • 批准号:
    10710311
  • 项目类别:
  • 资助金额:
    $41.31万
  • 财政年份:
    2022
  • 负责人:
    ROBERT GIANNINI
  • 依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data